Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Molecular Imaging Market Outlook

The global molecular imaging market is expected to secure US$ 5,437.2 million in 2023. During the forecast period, the market is projected to exhibit a CAGR of 11.0% while garnering US$ 15,457.48 million. The growth of the market can be attributed to the increasing incidences of chronic illness across the globe.

The increasing prevalence of chronic diseases like cancer and other genetic illnesses are expected to propel the demand for an efficient and early disease diagnosis, which is projected to benefit the global market during the forecast period.

Increasing adoption of molecular imaging for new applications, ongoing development and innovation in molecular imaging technologies, and developing economies are likely to provide significant opportunities for growth in the market in the coming time.

Furthermore, molecular imaging procedures have various benefits which are projected to augment the molecular imaging sector. Molecular imaging procedures are non-invasive, safe, and painless and are used to treat heart diseases, cancer, and disorders like Alzheimer’s and Parkinson’s disease, kidney and thyroid disorders, and others. Early detection of the diseases allows treatment on time when there may be a better prognosis.

Additionally, the introduction of new devices is likely to augment the market size during the forecast period. In January 2021, Molecular Devices LLC., a renowned provider of high-performance life science technology, launched its next-generation, high-content imaging system.

The new system provides faster image acquisition and multiplexing flexibility with high-performance lasers. Image analysis with machine learning allows researchers to quickly uncover new insights that are provable and repeatable with clarity, and accuracy. Such initiatives are expected to benefit the market growth in the forecast period.

Attribute Details
Molecular Imaging Market CAGR (2023 to 2033) 11%
Molecular Imaging Market Size (2023) US$ 5437.2 million
Molecular Imaging Market Size (2033) US$ 15,457.48 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Factors Hindering The Global Molecular Imaging Business

Expenses Associated with Molecular Imaging Systems to Hinder the Market

High expenses associated with advanced molecular imaging systems are projected to hamper the market growth during the forecast period. The presence of unfavorable reimbursements and a lack of expertise in developing countries hinder market growth.

However, the rapid growth of the geriatric population, and growing cases of Alzheimer’s disease, arthritis, dementia, and Parkinson’s disease, are expected to escalate the demand for molecular imaging devices, thus, benefitting the industry in the forecast period.

Key Trends in the Global Molecular Imaging Industry?

AI-Based Medical Equipment to Offer Remunerative Opportunities to the Molecular Imaging Business

The increasing application of AI-based diagnostic equipment for the rapid detection of illnesses is anticipated to act as a significant opportunity for the global market during the forecast period. Players in the market are introducing AI-based equipment which helps the market in fetching significant dividends.

In 2019, Siemens Healthineers introduced an ultrasound system, Acuson Redwood, which provides an imaging solution for clinical departments including cardiology, radiology, and gynecology.

Also, growing approvals of products by authorities further benefit the market. For instance, in December 2020, Hologic, Inc., announced that the USA FDA had approved Genius AI Detection technology for early detection of breast cancer. The advent of AI-based devices is projected to benefit the market in the coming time.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Global Molecular Imaging Industry Revenue Analysis 2018 to 2022 Vs Future Outlook 2023 to 2033

From 2018 to 2022, the global molecular imaging sector is expected to have displayed a CAGR of 9.3%. Expansion during the given time frame can be attributed to the growing demand for early detection tools, growth initiatives, and reimbursement initiatives undertaken by the government.

Also, the introduction of advanced equipment is another factor that is likely to have participated in market development. For instance, in August 2020, Philips expanded its cardiovascular ultrasound portfolio by launching Affinity CVs. Attributed to such factors, the market is likely to have displayed growth opportunities in the aforementioned forecast period.

During the forecast period, the global market is anticipated to display a CAGR of 11.0%. The development of the market is attributed to the introduction of advanced technologies. For instance, in 2021, GE Healthcare, a US-based player, launched Venue Fit.

It is a streamlined and compact POCUS system, along with the industry’s first AI offering for cardiology. Such initiatives are expected to benefit the market during the assessment tenure.

Prominent Factors In The Global Molecular Imaging Industry

Increasing demand for early detection and cost-effective diagnosis of chronic diseases along with the rising geriatric population across the globe are likely to fuel demand for the molecular imaging system. The advent of modern devices and developing healthcare infrastructure in evolving economies are some of the salient factors escalating market growth.

The launch of AI-based devices is projected to augment the market size in the coming time. For instance, in May 2020, Fujifilm Corporation launched AI-based technology for lung nodule detection. This technology is used to detect pulmonary nodules in chest CT scans to aid in lung cancer detection.

In another instance, in November 2020, Canon Medical Systems Corporation launched One-Beat Spectral Cardiac CT, with rapid kVp switching and deep learning spectral reconstruction to acquire whole-heart spectral images in one beat. Thus, the launch of advanced products is anticipated to benefit the industry during the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of the Market

Molecular Imaging Market:

Attributes Molecular Imaging Market
CAGR (2023 to 2033) 11.0%
Market Value (2033) US$ 15,457.48 million
Growth Factor Latest imaging techniques
Opportunity Rising geriatric population
Key Trends Launch of AI based devices

Dialysis Concentrate Market:

Attributes Dialysis Concentrate Market
CAGR (2023 to 2033) 5.4%
Market Value (2033) US$ 5,330 million
Growth Factor High number of people with hypertension and diabetes
Opportunity Product technology developments
Key Trends Payment from governments for kidney disease treatment

Dialysis Equipment Market:

Attributes Dialysis Equipment Market
CAGR (2023 to 2033) 4.8%
Market Value (2033) US$ 29,960 million
Growth Factor Increased government-backed investments in the healthcare sector
Opportunity Developments like the devices are designed for extracorporeal blood treatment
Key Trends Manufacturers are increasing their efforts to introduce new items

Segmentation Analysis

Hospital Segment Dominating the Global Molecular Imaging Industry

Availability of Modern Equipment in Hospitals to Boost the Segment Growth

As per the analysis, based on end-users, the hospital segment is anticipated to dominate the global molecular imaging sector. In 2022, the segment is projected to have claimed 56.5% of the global revenue.

Increasing demand for modern techniques and the availability of advanced services are likely to benefit segmental growth during the forecast period. Developed countries have shown a significant rise in demand for such setups. Attributed to such factors, the segment is projected to grow significantly in the forecast period.

Participation of Diagnostic Centers to Augment the Global Molecular Imaging Industry

Growing Demand for On-time Disease Detection to Propel the Segment Growth

Increasing demand for on-time detection and treatment of diseases is expected to benefit the molecular diagnostic segment during the forecast period. The growing number of diagnostic centers owing to consolidation in the market is likely to contribute to segmental growth in the forecast period.

Furthermore, increasing adoption of advanced technology and developed infrastructure are other factors contributing to the development of the segment.

Regional Analysis

Increasing Product Launches Strengthening the Molecular Imaging Sector in North America

According to the analysis, the global molecular imaging market is projected to be dominated by North America during the forecast period. In 2022, the region accounted for the leading market share of about 35.1%. Domination of the region is attributed to the presence of established players in the region taking various initiatives to launch new products.

Further, growing clearances of the product by the FDA are likely to widen the market growth scope in the coming time. For instance, in January 2019, United Imaging Healthcare announced the United States FDA of uEXPLORER total-body scanner. It is the globe’s first medical imaging scanner that captures a 3D image of the human body. Such factors are expected to benefit the global molecular imaging sector.

Technological Advancement Developing the Molecular Imaging Market in Europe

According to the analysis, the market for molecular imaging in Europe is anticipated to display a CAGR of 4% during the forecast period. In 2022, Europe held a significant share of 28.5%. Development of the market is attributed to the ongoing technological development in the market. For instance, in 2021, Koninklijke Philips launched the spectral detector-based Spectral Computed Tomography (CT) 7500 solution for accurate diagnosis.

Players receiving FDA clearances is another salient factor that is likely to develop the industry in the forecast period. For instance, in 2021, Siemens Healthineers received FDA clearance for the Biograph Vision Quadra, a CT scanner for clinical application. Such factors are likely to make a significant contribution to developing the market in Europe.

Rising Demand for Imaging Equipment Benefitting the Global Molecular Imaging Industry

According to the analysis, APAC is projected to be the fastest-growing market for the molecular imaging sector during the forecast period. The region is likely to display a CAGR of 6% during the timeframe of 2023 to 2033.

The development of the regional market is attributed to the increasing prevalence of chronic illness and the growing demand for developed diagnostic devices. Further, the rapid growth of healthcare infrastructure in evolving countries is another salient factor that strengthen the industry in the coming time.

Role Of Startups In Developing The Global Molecular Imaging Market

VoxelCloud (United States), Aldoc (Israel), Qure.ai (India), Zebra Medical Vision (Israel), HeartFlow (United States), Arterys (United States), Kheiron Medical Technologies (United Kingdom), and Lunit (South Korea), among others, are some of the emerging names in the global market.

Recent Updates from the Startup Landscape:

In March 2022, Healthtech Startup Qure.ai raised US$ 40 Million in a funding round led by Novo Holdings and HealthQuad. The existing investor MassMutual Ventures also participated in the round. The capital is used to strengthen its reach in the USA and Europe.

Recent Developments by Key Players in the Market:

In September 2021, Hermes Medical Solutions and Isotopia Molecular Imaging announced a new collaboration with Isotopia to raise awareness and co-promote the benefits of dosimetry, personalized medicine, and radiopharmaceutical therapy.

In February 2021, Royal Philips announced the acquisition of BioTelemetry, a USA-based player that provides remote cardiac diagnostics and monitoring. The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions.

Key players

  • Hermes Medical Solutions
  • Bruker Corporation
  • GE Company
  • Fujifilm Holdings Corp.
  • Koninklijke Philips N.V.
  • Siemens AG
  • Toshiba Medical System Corp.
  • Mirada Medical Limited
  • Carestream Health, Inc.
  • Esaote SpA
  • Positron Corporation
  • Medisco Ltd.
  • Hitachi Medical Corp.
  • MIM Software Inc.

Key segments

By Modality:

  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products

By Application:

  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal

By End Users:

  • Hospitals
  • Diagnostic Imaging Centres
  • Ambulatory Surgical Centres

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the CAGR from 2023 to 2033?

The CAGR for the market is 11% until 2033.

What was the share of the market in North America?

In 2022, the region accounted for the leading market share of about 35.1%.

What is the market size in 2023?

The market is valued at US$ 5,437.2 million in 2023.

What will the market size be in 2033?

The market will reach US$ 15,457.48 million by 2033.

What is the Asia Pacific’s CAGR of this market through 2033?

The Asia Pacific market is likely to display a CAGR of 6% through 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Modality, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality, 2023 to 2033

        5.3.1. Positron Emission Tomography (PET)

        5.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)

        5.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

        5.3.4. Single Photon Emission Computed Tomography (SPECT)

        5.3.5. Software

            5.3.5.1. On-Premises Solutions

            5.3.5.2. Cloud-Based Solutions

        5.3.6. Magnetic Resonance

        5.3.7. Molecular Ultrasound Imaging

    5.4. Y-o-Y Growth Trend Analysis By Modality, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Cardiology

        6.3.2. Oncology

        6.3.3. Gastrointestinal Disorders

        6.3.4. Neurology Disorders

        6.3.5. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033

        7.3.1. Hospitals

            7.3.1.1. 500+ Beds

            7.3.1.2. 200-499 Beds

            7.3.1.3. Less than 200 Beds

        7.3.2. Ambulatory Surgical Centres

        7.3.3. Diagnostic Centres

    7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Modality

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Modality

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Modality

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Modality

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Modality

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Modality

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Modality

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Modality

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Modality

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Modality

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Modality

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Modality

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Modality

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Modality

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Modality

            16.1.2.2. By Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Modality

            16.2.2.2. By Application

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Modality

            16.3.2.2. By Application

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Modality

            16.4.2.2. By Application

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Modality

            16.5.2.2. By Application

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Modality

            16.6.2.2. By Application

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Modality

            16.7.2.2. By Application

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Modality

            16.8.2.2. By Application

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Modality

            16.9.2.2. By Application

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Modality

            16.10.2.2. By Application

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Modality

            16.11.2.2. By Application

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Modality

            16.12.2.2. By Application

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Modality

            16.13.2.2. By Application

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Modality

            16.14.2.2. By Application

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Modality

            16.15.2.2. By Application

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Modality

            16.16.2.2. By Application

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Modality

            16.17.2.2. By Application

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Modality

            16.18.2.2. By Application

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Modality

            16.19.2.2. By Application

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Modality

            16.20.2.2. By Application

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Modality

            16.21.2.2. By Application

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Modality

            16.22.2.2. By Application

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Modality

            16.23.2.2. By Application

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Modality

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Hermes Medical Solutions

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Bruker Corporation

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. GE Company

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Fujifilm Holdings Corp.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Koninklijke Philips N.V.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Siemens AG

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Toshiba Medical System Corp.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Mirada Medical Limited

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Carestream Health, Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Esaote SpA

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. Positron Corporation

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. Medisco Ltd.

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Hitachi Medical Corp.

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

        18.1.14. MIM Software Inc.

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Western Europe Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 15: Western Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: Eastern Europe Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 19: Eastern Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: East Asia Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 27: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Modality, 2018 to 2033

Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Modality, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 17: Global Market Attractiveness by Modality, 2023 to 2033

Figure 18: Global Market Attractiveness by Application, 2023 to 2033

Figure 19: Global Market Attractiveness by End User, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Modality, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 37: North America Market Attractiveness by Modality, 2023 to 2033

Figure 38: North America Market Attractiveness by Application, 2023 to 2033

Figure 39: North America Market Attractiveness by End User, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Modality, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Modality, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Western Europe Market Value (US$ Million) by Modality, 2023 to 2033

Figure 62: Western Europe Market Value (US$ Million) by Application, 2023 to 2033

Figure 63: Western Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Western Europe Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 71: Western Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 77: Western Europe Market Attractiveness by Modality, 2023 to 2033

Figure 78: Western Europe Market Attractiveness by Application, 2023 to 2033

Figure 79: Western Europe Market Attractiveness by End User, 2023 to 2033

Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Eastern Europe Market Value (US$ Million) by Modality, 2023 to 2033

Figure 82: Eastern Europe Market Value (US$ Million) by Application, 2023 to 2033

Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 97: Eastern Europe Market Attractiveness by Modality, 2023 to 2033

Figure 98: Eastern Europe Market Attractiveness by Application, 2023 to 2033

Figure 99: Eastern Europe Market Attractiveness by End User, 2023 to 2033

Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: South Asia and Pacific Market Value (US$ Million) by Modality, 2023 to 2033

Figure 102: South Asia and Pacific Market Value (US$ Million) by Application, 2023 to 2033

Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033

Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 117: South Asia and Pacific Market Attractiveness by Modality, 2023 to 2033

Figure 118: South Asia and Pacific Market Attractiveness by Application, 2023 to 2033

Figure 119: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033

Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 121: East Asia Market Value (US$ Million) by Modality, 2023 to 2033

Figure 122: East Asia Market Value (US$ Million) by Application, 2023 to 2033

Figure 123: East Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: East Asia Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 129: East Asia Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 131: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 132: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 137: East Asia Market Attractiveness by Modality, 2023 to 2033

Figure 138: East Asia Market Attractiveness by Application, 2023 to 2033

Figure 139: East Asia Market Attractiveness by End User, 2023 to 2033

Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 141: Middle East and Africa Market Value (US$ Million) by Modality, 2023 to 2033

Figure 142: Middle East and Africa Market Value (US$ Million) by Application, 2023 to 2033

Figure 143: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033

Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Modality, 2018 to 2033

Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Modality, 2023 to 2033

Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Modality, 2023 to 2033

Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 157: Middle East and Africa Market Attractiveness by Modality, 2023 to 2033

Figure 158: Middle East and Africa Market Attractiveness by Application, 2023 to 2033

Figure 159: Middle East and Africa Market Attractiveness by End User, 2023 to 2033

Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Molecular Diagnostic Market

Published : March 2024

Healthcare

Molecular Spectroscopy Market

Published : October 2023

Explore Healthcare Insights

View Reports